Patient Acceptance of Whole Body Magnetic Resonance Angiography

This study has been completed.
Sponsor:
Collaborator:
Rigshospitalet, Denmark
Information provided by:
Copenhagen University Hospital at Herlev
ClinicalTrials.gov Identifier:
NCT00556101
First received: November 8, 2007
Last updated: August 18, 2009
Last verified: August 2009
  Purpose

Investigation of how the patients experience whole body MRA. After the WB-MRA the patients will fill in a questionnaire, that contains questions about the WB-MRA procedure and how the patient felt during the examination.

We expect that the patients will report a high degree of satisfaction with the WB-MRA procedure, with little discomfort.


Condition Intervention
Atherosclerosis
Intermittent Claudication
MRI
Procedure: Whole body magnetic resonance angiography

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Whole Body Magnetic Resonance Angiography: Questionnaire Examination of Patient Acceptance.

Resource links provided by NLM:


Further study details as provided by Copenhagen University Hospital at Herlev:

Primary Outcome Measures:
  • Patient acceptance of Whole body MRA

Estimated Enrollment: 81
Study Start Date: November 2007
Study Completion Date: July 2009
Detailed Description:

WB-MRA is performed in patients referred for conventional x-ray based angiography. The WB-MRA is performed first in all patients.

After both examinations are completed the patients will be asked to fill in a questionnaire containing questions about their experience of the 2 procedures.

We will then compare the results for the procedures.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with pheripheral arterial disease

Criteria

Inclusion Criteria:

  • Symptomatic lower extremity ischemia (claudication, ischemic wounds)
  • Referred to digital subtraction angiography (DSA)

Exclusion Criteria:

  • Renal insufficiency (GFR < 30 ml/min)
  • Contra-indications for MRI-examination (claustrophobia, metal-implants, pacemaker)
  • Dementia
  • Pregnancy/lactation
  • Allergy to gadolinium based MRI contrast agents
  • Acute disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00556101

Locations
Denmark
Department of Radiology, Herlev University Hospital
Herlev Copenhagen, Herlev, Denmark, DK2730
Sponsors and Collaborators
Copenhagen University Hospital at Herlev
Rigshospitalet, Denmark
Investigators
Study Chair: Henrik S Thomsen, Prof. MD. University Hospital at Herlev Copenhagen Denmark
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00556101     History of Changes
Other Study ID Numbers: WB-angio herlev 4
Study First Received: November 8, 2007
Last Updated: August 18, 2009
Health Authority: Denmark: National Board of Health

Keywords provided by Copenhagen University Hospital at Herlev:
Magnetic resonance
whole body
angiography
questionnaire

Additional relevant MeSH terms:
Atherosclerosis
Arteriosclerosis
Intermittent Claudication
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on August 26, 2014